Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer

Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer

BackgroundB and T lymphocyte attenuator (BTLA) is a co-signaling protein belonging to the CD28 immunoglobulin superfamily. However, the role of BTLA in prognosis and immunotherapy of colorectal cancer (CRC) remains unclear.MethodsWe evaluated the expression of BTLA via the Oncomine and the cancer ge...

Full description

Bibliographic Details
Main Authors:	Jingjing Song, Lihui Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-07-01
Series:	Frontiers in Molecular Biosciences
Subjects:	BTLA tumor-infiltration prognosis colorectal cancer immunotherapy
Online Access:	https://www.frontiersin.org/article/10.3389/fmolb.2020.00148/full

Similar Items

BTLA biology in cancer: from bench discoveries to clinical potentials
by: Anna Andrzejczak, et al.
Published: (2024-01-01)

Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy
by: Christian Sordo-Bahamonde, et al.
Published: (2023-08-01)

BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM
by: Claire Battin, et al.
Published: (2022-08-01)

Combined Immunotherapy With Belatacept and BTLA Overexpression Attenuates Acute Rejection Following Kidney Transplantation
by: Hengcheng Zhang, et al.
Published: (2021-02-01)

Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature
by: Xian-wen Guo, et al.
Published: (2023-08-01)

Tumor Cell-Intrinsic BTLA Receptor Inhibits the Proliferation of Tumor Cells via ERK1/2
by: Tian-You Cheng, et al.
Published: (2022-12-01)

Lymphocyte HVEM/BTLA co-expression after critical illness demonstrates severity indiscriminate upregulation, impacting critical illness-induced immunosuppression
by: Michelle E. Wakeley, et al.
Published: (2023-05-01)

The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers
by: Anna Andrzejczak, et al.
Published: (2023-01-01)

The Role of the Inhibitory Ligand HVEM and Its Receptors CD160 and BTLA in the Regulation of Anti-retroviral T Cell Responses
by: Paul David, et al.
Published: (2022-03-01)

Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer
by: Jian-yu Shi, et al.
Published: (2021-04-01)

Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
by: Janina Świderska, et al.
Published: (2022-01-01)

The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells
by: Kai Werner, et al.
Published: (2019-12-01)

Internal regulation between constitutively expressed T cell co-inhibitory receptors BTLA and CD5 and tolerance in recent thymic emigrants
by: Adeolu O. Adegoke, et al.
Published: (2024-10-01)

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response
by: Jihong Huang, et al.
Published: (2022-11-01)

Subset of DN Memory B Cells Expressing Low Levels of Inhibitory Receptor BTLA Is Enriched in SLE Patients
by: Lucie Aubergeon, et al.
Published: (2024-12-01)

The Methylation in B7-H4 and BTLA Genes are Associated with the Risk of Pulmonary Tuberculosis
by: Cai XQ, et al.
Published: (2023-11-01)

SCG2: A Prognostic Marker That Pinpoints Chemotherapy and Immunotherapy in Colorectal Cancer
by: Siyuan Weng, et al.
Published: (2022-07-01)

The Prognostic Significance of RIMKLB and Related Immune Infiltrates in Colorectal Cancers
by: Yinghao Cao, et al.
Published: (2022-04-01)

A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer
by: Yu Xiao, et al.
Published: (2023-05-01)

Distinct characteristics of BTLA/HVEM axis expression on Tregs and its impact on the expansion and attributes of Tregs in patients with active pulmonary tuberculosis
by: Peijun Tang, et al.
Published: (2024-09-01)

Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer
by: Cheng Zhu, et al.
Published: (2022-10-01)

The effect of gD-derived peptides on T cell immune response mediated by BTLA-HVEM protein complex in melanoma patients
by: Karolina Wojciechowicz, et al.
Published: (2024-05-01)

HIV Infection Is Associated With Downregulation of BTLA Expression on Mycobacterium tuberculosis-Specific CD4 T Cells in Active Tuberculosis Disease
by: Morgan S. Barham, et al.
Published: (2019-08-01)

Prognostic value of inflammatory and immune markers in resectable colorectal cancer
by: MA Yifei , LIANG Xinjun , WEI Shaozhong
Published: (2021-09-01)

BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production
by: Lidia Karabon, et al.
Published: (2021-11-01)

The Role of RNA Methylation Modification Related Genes in Prognosis and Immunotherapy of Colorectal Cancer
by: Lin R, et al.
Published: (2023-05-01)

Analysis of the role of CHPF in colorectal cancer tumorigenesis and immunotherapy based on bioinformatics and experiments
by: Qingyu Song, et al.
Published: (2024-09-01)

Identification of angiogenesis-related subtypes, the development of prognostic models, and the landscape of tumor microenvironment infiltration in colorectal cancer
by: Chen Zhang, et al.
Published: (2023-02-01)

17β-estradiol in colorectal cancer: friend or foe?
by: Zihong Wu, et al.
Published: (2024-07-01)

Variation in the gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma – results of a prospective cohort study
by: Krzysztof Tupikowski, et al.
Published: (2021-09-01)

Progress on Tumor Infiltrating Lymphocytes in Immunotherapy and Prognosis Evaluation of Breast Cancer
by: HONG Chenchen, et al.
Published: (2022-11-01)

An integrative prognostic and immune analysis of PTPRD in cancer
by: Chunpei Ou, et al.
Published: (2022-03-01)

Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
by: Daniele Fanale, et al.
Published: (2022-09-01)

Neutrophils in Cancer immunotherapy: friends or foes?
by: Xueqin Huang, et al.
Published: (2024-05-01)

Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer
by: Hang Zheng, et al.
Published: (2022-06-01)

High expression of PDCD11 in colorectal cancer and its correlation with the prognosis and immune cell infiltration
by: Xiongfeng Li, et al.
Published: (2024-08-01)

Novel biomarkers: the RUNX family as prognostic predictors in colorectal cancer
by: Yingting Liu, et al.
Published: (2024-12-01)

HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma
by: Fu-xue Huang, et al.
Published: (2022-08-01)

Development of an anoikis-related gene signature and prognostic model for predicting the tumor microenvironment and response to immunotherapy in colorectal cancer
by: Chuanchang Li, et al.
Published: (2024-05-01)

CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer
by: Xueli Wang, et al.
Published: (2023-05-01)